These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18398100)

  • 1. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Vaidya JS
    J Natl Cancer Inst; 2008 Apr; 100(8):598-9; author reply 599. PubMed ID: 18398100
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Byers T; Trujillo S; Hines L
    J Natl Cancer Inst; 2008 Apr; 100(8):596. PubMed ID: 18398102
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Chu DZ
    J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L
    J Natl Cancer Inst; 2008 Apr; 100(8):597-8; author reply 599. PubMed ID: 18398101
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Robbins AS; Clarke CA
    J Natl Cancer Inst; 2007 Dec; 99(23):1815; author reply 1816-7. PubMed ID: 18042938
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Anderson BO
    J Natl Cancer Inst; 2007 Dec; 99(23):1815-6; author reply 1816-7. PubMed ID: 18042937
    [No Abstract]   [Full Text] [Related]  

  • 7. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Kerlikowske K; Miglioretti DL; Buist DS; Walker R; Carney PA;
    J Natl Cancer Inst; 2007 Sep; 99(17):1335-9. PubMed ID: 17698950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
    Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
    J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer incidence and use of hormone therapy in Denmark 1978-2007.
    von Euler-Chelpin M
    Cancer Causes Control; 2011 Feb; 22(2):181-7. PubMed ID: 21103920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Ponti A; Rosso S; Zanetti R; Ricceri F; Tomatis M; Segnan N
    J Natl Cancer Inst; 2007 Dec; 99(23):1817-8; author reply 1819. PubMed ID: 18042935
    [No Abstract]   [Full Text] [Related]  

  • 12. Postmenopausal hormone therapy and prevalent round screening mammography.
    Sweeney KJ; Boran S; Fitzpatrick P; Merrigan AB; Moran R; Flanagan F; Kerin MJ
    Int J Cancer; 2009 Mar; 124(6):1490-1. PubMed ID: 19065663
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?
    Parkin DM
    Eur J Cancer; 2009 Jun; 45(9):1649-53. PubMed ID: 19217279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is estrogen therapy of significance for the incidence of breast cancer?].
    Bakken K
    Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2801; author reply 2801. PubMed ID: 15534689
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
    Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
    Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices.
    LeBlanc ES; Viscoli CM; Henrich JB
    J Womens Health Gend Based Med; 1999; 8(6):815-23. PubMed ID: 10495262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the effect of hormone replacement therapy on the performance of screening mammography.
    Thomas CM
    Radiology; 1999 Dec; 213(3):926-7. PubMed ID: 10580977
    [No Abstract]   [Full Text] [Related]  

  • 18. A decline in breast-cancer incidence.
    Zahl PH; Maehlen J
    N Engl J Med; 2007 Aug; 357(5):510-1; author reply 513. PubMed ID: 17674462
    [No Abstract]   [Full Text] [Related]  

  • 19. Postmenopausal estrogen use and invasive versus in situ breast cancer risk.
    Henrich JB; Kornguth PJ; Viscoli CM; Horwitz RI
    J Clin Epidemiol; 1998 Dec; 51(12):1277-83. PubMed ID: 10086820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer decline mirrors fall in hormone use, spurs both debate and research.
    McNeil C
    J Natl Cancer Inst; 2007 Feb; 99(4):266-7. PubMed ID: 17312300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.